To the editor: The rapid development in treatment options for patients with chronic lymphocytic leukemia (CLL) in parallel with a much more detailed understanding of the underlying pathogenesis has warranted the development of novel prognostic indices for patients with CLL to replace the clinical
No takes yet. Share an insight, caveat, or question.
Cunha‐Bang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: